Cargando…

Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial

BACKGROUND: The risk for and treatment of cardiovascular disease (CVD) in type 2 diabetes (T2DM) is often incorrect and delayed. We wished to determine if a novel test improved physicians’ ability to risk stratify, diagnose, and treat patients with T2DM. METHODS: In a 2-phase randomized controlled t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peabody, John W., Paculdo, David, de Belen, Enrico, Ganesan, Divya, Cooney, Isabella, Trujillo, Nelson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339653/ https://www.ncbi.nlm.nih.gov/pubmed/37438853 http://dx.doi.org/10.1186/s13098-023-01122-w

Ejemplares similares

Clinical Variation in the Treatment Practices for Patients With Type 2 Diabetes: A Cross‐Sectional Patient Simulation Study Among Primary Care Physicians and Cardiologists
por: De Belen, Enrico, et al.
Publicado: (2023)

Establishing Clinical Utility for Diagnostic Tests Using a Randomized Controlled, Virtual Patient Trial Design
por: Peabody, John, et al.
Publicado: (2019)

Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
por: Peabody, John W, et al.
Publicado: (2023)

Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
por: Peabody, John, et al.
Publicado: (2021)

Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain
por: Peabody, John, et al.
Publicado: (2020)

Clinical Utility of Definitive Drug–Drug Interaction Testing in Primary Care
por: Peabody, John, et al.
Publicado: (2018)

Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial
por: Burgon, Trever, et al.
Publicado: (2021)

Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug–Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians
por: Valdenor, Czarlota, et al.
Publicado: (2022)

Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices
por: Peabody, John, et al.
Publicado: (2016)

Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
por: Peabody, John, et al.
Publicado: (2020)

Clinical variation in surveillance and management of Barrett’s esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons
por: Cruz, Jamielyn DC, et al.
Publicado: (2022)

Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice
por: Peabody, John, et al.
Publicado: (2019)

Gaps in the Care of Pulmonary Hypertension: A Cross‐Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists
por: de Belen, Enrico, et al.
Publicado: (2023)

Drug-Drug Interaction Assessment and Identification in the Primary Care Setting
por: Peabody, John, et al.
Publicado: (2018)

Comparative effectiveness of two disparate policies on child health: experimental evidence from the Philippines
por: Peabody, John W, et al.
Publicado: (2017)

Initiative to Improve Evidence-Based Chronic Obstructive Pulmonary Disease Hospitalist Care Using a Novel On-Line Gamification Patient Simulation Tool: A Prospective Study
por: Strong, Jodi, et al.
Publicado: (2021)

Improving Clinical Practice Using a Novel Engagement Approach: Measurement, Benchmarking and Feedback, A Longitudinal Study
por: Peabody, John W., et al.
Publicado: (2016)

Standardising practice in cardiology: reducing clinical variation and cost at Ochsner Health System
por: Oravetz, Phil, et al.
Publicado: (2019)

Diabetes Mellitus Type 2 and Cardiovascular Diseases-Risk Assessment
por: Avdagic-Terzic, Mirsada, et al.
Publicado: (2022)

Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
por: Hinnen, Deborah, et al.
Publicado: (2019)

Supervised exercise training reduces oxidative stress and cardiometabolic risk in adults with type 2 diabetes: a randomized controlled trial
por: Vinetti, Giovanni, et al.
Publicado: (2015)

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
por: Cobble, Michael E, et al.
Publicado: (2012)

Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus
por: Wakasaki, Hisao, et al.
Publicado: (2020)

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease
por: Pantalone, Kevin M., et al.
Publicado: (2018)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

Effects of dapagliflozin on cardiovascular outcomes in type 2 diabetes: Study protocol of a randomized controlled trial
por: Yin, Dong, et al.
Publicado: (2020)

A randomized controlled trial protocol of the cardiovascular safety and efficacy of liraglutide in the treatment of type 2 diabetes
por: Liang, Ying, et al.
Publicado: (2021)

SAT-668 Liver Function Test in Type 1 Diabetes Mellitus and Prevalence of Other Autoimmune Disease in Type 1 Diabetes Mellitus
por: Anusha, Nadig, et al.
Publicado: (2020)

CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial
por: Corella, Dolores, et al.
Publicado: (2016)

Utility of Tissue Inhibitor Metalloproteinase-1 and Osteopontin as Prospective Biomarkers of Early Cardiovascular Complications in Type 2 Diabetes
por: El-Din, Doaa Samir Salah, et al.
Publicado: (2018)

Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial
por: Peabody, John W., et al.
Publicado: (2017)

Assessment of Triglyceride Glucose Index in Type 2 Diabetes Mellitus Patients With and Without Cardiac Autonomic Neuropathy
por: Jeyaseeli, Angeline, et al.
Publicado: (2023)

Utility of Insulin Resistance in Estimating Cardiovascular Risk in Subjects with Type 1 Diabetes According to the Scores of the Steno Type 1 Risk Engine
por: Cano, Albert, et al.
Publicado: (2020)

A Comparative Assessment of Cardiovascular Autonomic Reflex Testing and Cardiac (123)I-Metaiodobenzylguanidine Imaging in Patients with Type 1 Diabetes Mellitus without Complications or Cardiovascular Risk Factors
por: Didangelos, Triantafyllos, et al.
Publicado: (2018)

Utility of oral glucose tolerance test in predicting type 2 diabetes following gestational diabetes: Towards personalized care
por: Bayoumi, Riad Abdel Latif, et al.
Publicado: (2021)

A nationwide program to improve clinical care quality in the Kyrgyz Republic
por: Peabody, John W, et al.
Publicado: (2020)

Clinical implications of cardiovascular outcome trials in type 2 diabetes
por: Mellbin, L. G., et al.
Publicado: (2019)

Assessment of the Risk of Type 2 Diabetes Mellitus Among a Rural Population in South India Using the Indian Diabetic Risk Score
por: Jeyaseeli V, Angeline, et al.
Publicado: (2023)

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials
por: Iqbal, Nayyar, et al.
Publicado: (2014)

Assessing the clinical utility of the diabetes eating problem survey‐revised (DEPS‐R) in adolescents with type 1 diabetes
por: Ryman, Brianna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ml65gg78db3i02mv0rfig73gaq